Showing 421 - 440 results of 605 for search '"smoking cessation"', query time: 0.07s Refine Results
  1. 421

    The "Help Your Patient Stop" initiative. Evaluation of smoking prevalence and dissemination of WHO/UICC guidelines in UK general practice. by Fowler, G, Mant, D, Fuller, A, Jones, L

    Published 1989
    “…The World Health Organisation and the International Agency against Cancer in 1988 published joint guidelines on smoking cessation for primary health care teams. A booklet entitled Help Your Patient Stop was produced in the United Kingdom as a model for the international dissemination of these guidelines. …”
    Journal article
  2. 422

    Professional Doctorate in Health Psychology: Competence Assessments by Anastasi, Natasha Angela

    Published 2015
    “…The model did however show that proportion of time spent delivering smoking cessation support significantly influenced quit rate. …”
    Get full text
    Thesis
  3. 423

    Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis by Kar, D, Gillies, C, Zaccardi, F, Webb, D, Seidu, S, Tesfaye, S, Davies, M, Khunti, K

    Published 2016
    “…In addition to other concomitant vascular perturbations, it also seems to influence the cardiometabolic parameters, which may partly explain the accelerated rate of vascular complications in smokers with diabetes. While smoking cessation is advocated as a universal component of the management of diabetes, there is some anecdotal evidence that HbA1c could increase following smoking cessation. …”
    Journal article
  4. 424

    Chronic obstructive pulmonary disease: Management of chronic disease by Russell, R, Norcliffe, J, Bafadhel, M

    Published 2012
    “…Cigarette smoking is the major cause of the disease and smoking cessation is the most effective intervention in both preventing disease development and progression. …”
    Journal article
  5. 425

    Pooling data for number needed to treat: No problems for apples by Moore, R, Gavaghan, D, Edwards, J, Wiffen, P, McQuay, H

    Published 2002
    “…Objective: To consider the problem of the calculation of number needed to treat (NNT) derived from risk difference, odds ratio, and raw pooled events shown to give different results using data from a review of nursing interventions for smoking cessation. Discussion: A review of nursing interventions for smoking cessation from the Cochrane Library provided different values for NNT depending on how NNTs were calculated. …”
    Journal article
  6. 426

    An exploratory pilot study of the relationship between neural correlates of cognitive control and reduction in cigarette use among treatment-seeking adolescent smokers. by Krishnan-Sarin, S, Balodis, I, Kober, H, Worhunsky, P, Liss, T, Xu, J, Potenza, M

    Published 2013
    “…Despite high rates of tobacco use during adolescence, few empirically validated smoking cessation strategies exist for adolescent smokers. …”
    Journal article
  7. 427

    Pooling data for Number Needed to Treat: no problems for apples by Moore, R, Gavaghan, D, Edwards, J, Wiffen, P, McQuay, H

    Published 2002
    “…Objective: To consider the problem of the calculation of number needed to treat (NNT) derived from risk difference, odds ratio, and raw pooled events shown to give different results using data from a review of nursing interventions for smoking cessation. Discussion: A review of nursing interventions for smoking cessation from the Cochrane Library provided different values for NNT depending on how NNTs were calculated. …”
    Journal article
  8. 428

    The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG. by Beaver, J, Long, C, Cole, D, Durcan, M, Bannon, L, Mishra, R, Matthews, P

    Published 2011
    “…We used functional MRI with simultaneous electroencephalogram (EEG) recording to define brain activity correlates of cognitive impairment with short-term smoking cessation in habitual smokers and the effects of nicotine replacement. …”
    Journal article
  9. 429

    A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms. by Ussher, M, Aveyard, P, Reid, F, West, R, Evans, P, Clow, A, Hucklebridge, F, Fuller, J, Ibison, J, Steptoe, A

    Published 2011
    “… RATIONALE: Many smokers experience a decline in cortisol to sub-normal levels during the first days of smoking cessation. A greater decline in cortisol is associated with more intense cigarette withdrawal symptoms, urge to smoke and relapse to smoking. …”
    Journal article
  10. 430

    The role of psychiatrists and tobacco dependence treatment by Amer Nordin, A.S., Sellman, J.D., Adamson, S.J.

    Published 2014
    “…Methods: The literature search utilised MEDLINE, Embase and PsychINFO databases using the terms psychiatry, psychiatrist, smoking cessation, tobacco use disorder and tobacco dependence treatment. …”
    Get full text
    Article
  11. 431

    Mediators of the effect of nicotine pre-treatment on quitting smoking by Hajek, P, Lewis, S, Munafo, M, Lindson, N, Coleman, T, Aveyard, P

    Published 2018
    “… <h4>Background and aims</h4> <p>Using smoking cessation medications for several weeks prior to quitting smoking facilitates quitting success, but how it does so is not clear. …”
    Journal article
  12. 432

    Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. by Munafò, M, Bradburn, M, Bowes, L, David, S

    Published 2004
    “…Smoking-related death and disability rates for women have risen sharply recently. Despite lower smoking cessation success rates for women using behavioral therapies, data are limited on whether specific pharmacological therapies are equally efficacious in men and women. …”
    Journal article
  13. 433

    The genetic basis for smoking behavior: a systematic review and meta-analysis. by Munafò, M, Clark, T, Johnstone, E, Murphy, M, Walton, R

    Published 2004
    “…Evidence indicated effects of the DRD2 Taq1A polymorphism and smoking initiation, the 5HTT LPR and CYP2A6 reduced-activity polymorphisms and smoking cessation, and the DRD2 Taq1A and CYP2A6 reduced-activity polymorphisms and cigarette consumption. …”
    Journal article
  14. 434

    Surgical lung cancer patients' views about smoking and support to quit after diagnosis: a qualitative study by Farley, A, Aveyard, P, Kerr, A, Naidu, B, Dowswell, G

    Published 2015
    “…Evidence suggests that quitting smoking improves symptoms as well as disease-related mortality for cancer patients. However, smoking cessation support is typically not well integrated into routine cancer care even in the case of lung cancer.. …”
    Journal article
  15. 435

    Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis by Munafò, M, Bradburn, M, Bowes, L, David, S

    Published 2004
    “…Smoking-related death and disability rates for women have risen sharply recently. Despite lower smoking cessation success rates for women using behavioral therapies, data are limited on whether specific pharmacological therapies are equally efficacious in men and women. …”
    Journal article
  16. 436

    Does cigarette reduction while using nicotine replacement therapy prior to a quit attempt predict abstinence following quit date? by Lindson-Hawley, N, Shinkins, B, West, R, Michie, S, Aveyard, P

    Published 2016
    “…Previous studies have reported that people who use a smoking cessation medication while smoking and reduce cigarette consumption spontaneously are three times more likely to stop smoking after a quit date. …”
    Journal article
  17. 437

    Women's longitudinal patterns of smoking during the pre-conception, pregnancy and postnatal period: evidence from the UK infant feeding survey by Fitzpatrick, K, Gray, R, Quigley, M

    Published 2016
    “…CONCLUSION: Health professionals should ask about smoking at every opportunity, and refer women who self-report as current smokers to an evidence based smoking cessation service.…”
    Journal article
  18. 438

    Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: Protocol for a cluster randomised controlled trial by Sohanpal, R, Jumbe, S, James, W-Y, Steed, L, Yau, T, Rivas, C, Madurasinghe, V, Houlihan, C, Berdunisov, V, Taylor, M, Taylor, SJC, Griffiths, C, Eldridge, S, Walton, R

    Published 2019
    “…<p><strong>Background:</strong><br /> NHS community pharmacies provide effective smoking cessation services; however, there is scope for increasing throughput and improving quit rates. …”
    Journal article
  19. 439

    English Stop-Smoking Services: One-Year Outcomes. by Bauld, L, Hiscock, R, Dobbie, F, Aveyard, P, Coleman, T, Leonardi-Bee, J, McRobbie, H, McEwen, A

    Published 2016
    “…Improving abstinence is likely to require a greater emphasis on providing specialist smoking cessation support. Results from this study suggest that over 18,000 premature deaths were prevented through longer-term smoking cessation achieved by smokers who accessed SSS in England from March 2012 to April 2013, but outcomes varied by client characteristic and the type of support provided.…”
    Journal article
  20. 440

    Stop smoking clinics in Malaysia: characteristics of attendees and predictors of success by Wee, L.H., Shahab, L., Bulgiba, A., West, R.

    Published 2011
    “…Conclusion: In these rare data from a non-Western culture some predictors of successful smoking cessation appeared to generalise from Western smokers but the universal validity of the FTND in particular needs to be examined further. …”
    Get full text
    Article